Research aimed at improving long-term outlook for stroke patients

The long-term consequences of a stroke often are more severe than the attack itself, a medical reality that researcher Shaohua Yang, PhD, MD, hopes to alter.

"A stroke is like an earthquake," said Dr. Yang, Associate Professor of Pharmacology and Neuroscience at UNTHSC. "It triggers a lot of other problems downstream."

Brain damage, loss of motor function and long-term disability are among the problems suffered by more than 800,000 stroke patients each year. About 25 percent to 30 percent of stroke survivors develop dementia, often within the first year of recovery. Having a stroke doubles the risk of developing dementia.

Dr. Yang, who recently received a $1.6 million grant from the National Institute of Neurological Disorders and Stroke, hopes to improve the long-term outlook for stroke patients by studying how a specific molecule called  a neuroglobin makes the brain less susceptible to stroke.

Studies have shown that an increase in neoglobin in the brain leads to less damage in an ischemic stroke, which occurs when an artery to the brain is block and accounts for 88 percent of all strokes.

"We believe that this molecule plays a major role in brain metabolism," he said. "By manipulating this molecule, we hope to find new treatments that could slow down or prevent dementia and other functional deficits following a stroke."

Over the last two decades, the treatment for ischemic stroke has improved with the delivery of the drug tPA. It is the only drug approved to dissolve blood clots that cause most strokes. But tPA must be administered intravenously and only works if given within three hours after the onset of stroke symptoms.

"Few patients get to the hospital in time to qualify for the drug," Dr. Yang said.

Patients are often disqualified from receiving the drug because they delayed going to the hospital or failed to recognize the symptoms of a stroke.

As part of Dr. Yang’s research, he is trying to identify a neuropathway that may prevent or at least provide protection against both the primary and secondary brain damage triggered by a stroke.

"If we can identify the pathway, we can develop new drugs to treat strokes and improve recovery," he said. "Our hope then is to expand treatment to other diseases."

Recent News

Tarri Wyre
  • On Campus
|Sep 26, 2023

SaferCare Texas empowers Community Health Workers to complete HSC Mental Wellness microcredential

Tarri Wyre saw the growing need to expand her mental health education. The community health worker and ambulatory care manager for Memorial Hermann Health in Houston turned to the Mental Wellness microcredential, offered by The University of North Texas Health Science Center at Fort Worth’s SaferC...
Dr. Teresa Wagner
  • On Campus
|Sep 25, 2023

Two HSC programs to host maternal health conference centered on fourth trimester

In the U.S., more than 20% of maternal deaths during pregnancy and the first year after childbirth are because of drug use, suicide or homicide, according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. In the absence of access to mental...
Jessica Rangel
  • Our People
|Sep 25, 2023

This is Whole Health: Jessica Rangel

“Many years ago, I did a home visit on an older adult whom I had cared for numerous times in the emergency department. What I knew was that she suffered from a complicated medical situation and was not receiving optimal care with periodic emergency department visits. She always came by ambulance, ...
Ashenafi 768x768
  • Our People
|Sep 20, 2023

Dr. Ashenafi Cherkos awarded prestigious AIM-AHEAD Fellowship in Leadership

Dr. Ashenafi Cherkos, assistant professor at The University of North Texas Health Science Center at Fort Worth, has been awarded the prestigious AIM-AHEAD Fellowship in Leadership for the Fall 2023 cohort. Cherkos serves in the School of Public Health’s Department of Population and Community Healt...